Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02916472 · ClinicalTrials.gov registry record · NA

CyberCycling to Reduce Therapeutic Side Effects and Improve Quality of Life in AYA Cancers

A NA study, sponsored by Case Comprehensive Cancer Center.

Completed
Registry status
NA
Development phase
9
Enrollment target

NCT02916472: Completed NA study, sponsored by Case Comprehensive Cancer Center.

NCT02916472 is a NA study that has completed, run by Case Comprehensive Cancer Center. The registered enrollment target is 9 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02916472, a NA study, has completed, sponsored by Case Comprehensive Cancer Center.

COMPLETED
Registry status
NA
Development phase
9 participants
Enrollment target

Study Summary

Only a few clinical trials evaluating the potential benefits of exercise have been conducted in adolescents and young adults (AYA) with cancer and, no prior studies have evaluated the potential effects of 'cybercycling' (exergaming on a stationary bike) in AYA cancer survivors. Therefore, the study aims to conduct a pilot trial to determine feasibility (adherence, user acceptance) and to explore potential effects of a 'cybercycling' exercise program on fitness, body composition, quality of life, sleep and cognition.

Primary Outcome

Adherence rates will be summarized separately by treatment arm with proportions and exact confidence intervals. Feasibility will be defined as an adherence of greater than or equal to 80%

Interventions

  • BEHAVIORAL Stretching
  • BEHAVIORAL CyberCycling
  • BEHAVIORAL Resistance Bands

Trial Details

FieldValue
Enrollment Target 9 participants
Start Date 2016-08-24
Est. Completion 2024-02-23
Phase NA
Case Comprehensive Cancer Center

407 total trials

What the finished NCT02916472 record still lists

NCT02916472 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 9 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 3 interventions - of which Stretching is the first listed.

NCT02916472 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02916472 about?

NCT02916472 is a clinical study titled "CyberCycling to Reduce Therapeutic Side Effects and Improve Quality of Life in AYA Cancers". Only a few clinical trials evaluating the potential benefits of exercise have been conducted in adolescents and young adults (AYA) with cancer and, no prior studies have evaluated the potential effects of 'cybercycling' (exergaming on a stationary bike) in AYA cancer survivors. Therefore, the study ...

What is the current status of trial NCT02916472?

This trial is currently completed. It is a NA study. The enrollment target is 9 participants. The study started on 2016-08-24. Estimated completion is 2024-02-23.

What interventions are being tested in trial NCT02916472?

The interventions under investigation include: Stretching (BEHAVIORAL), CyberCycling (BEHAVIORAL), Resistance Bands (BEHAVIORAL).

Who is sponsoring clinical trial NCT02916472?

This trial is sponsored by Case Comprehensive Cancer Center, which has 407 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02916472's enrollment target sits among peer trials

9 1975th of 2000 higher than 25 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT02916472, the US trial registry maintained by the National Library of Medicine. NCT02916472 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.